Skip to main content

Gilead Sciences Expands Edmonton R&D Campus

Published 6/30/2015

Gilead Sciences opened a 45,000-sf pharmaceutical manufacturing laboratory in May of 2015 in Edmonton, Alberta. The facility is part of a two-building, $200 million campus expansion to support the production of Active Pharmaceutical Ingredients (APIs). The second buiding is currently under construction and will provide 139,000 sf of research and developent space when it opens in spring of 2016.